Pink SheetUS President Donald Trump has announced a general 26% reciprocal tariff on India, but a country-agnostic exemption of categories like pharmaceuticals implies that Indian pharma firms will not be direc
ScripEli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec
Generics BulletinA US federal district court did not err when it held that the US Patent and Trademark Office calculated correctly the five-year patent term extension entitled to a reissued patent shielding Merck &
Pink SheetSwami Iyer, the CEO for generic drug supplier Aurobindo’s US arm, Aurobindo Pharma USA Inc., downplayed tariff concerns, saying “It’s a lot of noise right now.” “We don’t know what’s the final outcome